Published in J Clin Oncol on May 01, 2001
Mortality results from a randomized prostate-cancer screening trial. N Engl J Med (2009) 30.05
Novel diagnostic biomarkers for prostate cancer. J Cancer (2010) 1.36
Overdiagnosis and overtreatment of early detected prostate cancer. World J Urol (2007) 1.05
1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells. Br J Cancer (2003) 0.86
Role of Chemokines and Chemokine Receptors in Prostate Cancer Development and Progression. J Cancer Sci Ther (2010) 0.83
Exercise therapy for sexual dysfunction after prostate cancer. Nat Rev Urol (2013) 0.79
Dosimetric and radiobiological comparison of CyberKnife M6™ InCise multileaf collimator over IRIS™ variable collimator in prostate stereotactic body radiation therapy. J Med Phys (2016) 0.78
Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of green tea in preventing acute gastrointestinal complications due to radiotherapy. J Res Med Sci (2014) 0.77
Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies. BMC Cancer (2014) 0.75
Radical radiotherapy for high-risk prostate cancer in older men. Oncologist (2012) 0.75
Prostate Cancer Screening: A Brief Tool to Incorporate Patient Preferences in a Clinical Encounter. Front Oncol (2016) 0.75
Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer. Radiother Oncol (2016) 0.75
Development of a comorbidity index using physician claims data. J Clin Epidemiol (2000) 19.31
Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol (2001) 11.17
Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA (2000) 6.37
Prostate cancer screening: what we know and what we need to know. Ann Intern Med (1993) 5.84
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. JAMA (1993) 5.48
Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst (2000) 4.89
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA (2000) 4.08
The role of increasing detection in the rising incidence of prostate cancer. JAMA (1995) 3.79
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res (2000) 3.65
Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA (1999) 3.37
Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc Natl Acad Sci U S A (2000) 3.24
The meaning and structure of species as applied to mycobacteria. Tubercle (1974) 3.22
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Give us this day our daily germs. Immunol Today (1998) 3.19
Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Med Care (1999) 3.15
Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst (2001) 3.00
Mycobacteria as a possible cause of inflammatory bowel disease. Lancet (1978) 2.94
Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst (1996) 2.91
Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med (1996) 2.90
A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc Natl Acad Sci U S A (1992) 2.76
I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages. Clin Exp Immunol (1985) 2.73
Estimating the risk of breast cancer in relation to the interval since last term pregnancy. Epidemiology (1997) 2.72
Breast cancer among black and white women in the 1980s. Changing patterns in the United States by race, age, and extent of disease. Cancer (1993) 2.70
Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis. Ann Intern Med (2000) 2.65
A co-operative numerical analysis of rapidly growing mycobacteria. J Gen Microbiol (1972) 2.63
Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J Natl Cancer Inst (1999) 2.59
Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care (1995) 2.55
Determining cause of death in prostate cancer: are death certificates valid? J Natl Cancer Inst (2001) 2.46
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (1998) 2.43
How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle (1981) 2.34
Blood lead and blood pressure. Relationship in the adolescent and adult US population. JAMA (1985) 2.33
Who gets chemotherapy for metastatic lung cancer? Chest (2000) 2.27
Characteristics of women with and without breast augmentation. JAMA (1997) 2.26
Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae. Res Vet Sci (1995) 2.25
Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc Natl Acad Sci U S A (1991) 2.17
Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2001) 2.13
Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet (1999) 2.12
Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst (2001) 2.09
Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst (2000) 2.07
A preliminary report on some studies of environmental mycobacteria. Ann Soc Belg Med Trop (1973) 2.06
Cellular immune response to common mycobacterial antigens in subjects seropositive for Trypanosoma cruzi. Lancet (1994) 2.06
Multiple skin testing in leprosy. J Hyg (Lond) (1975) 2.04
The production and preliminary investigation of Burulin, a new skin test reagent for Mycobacterium ulcerans infection. J Hyg (Lond) (1975) 2.02
Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science (1990) 2.00
Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res (1997) 2.00
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control (2000) 2.00
Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells. J Urol (1997) 1.98
An evaluation of a food frequency questionnaire for assessing dietary intake of specific carotenoids and vitamin E among low-income black women. Am J Epidemiol (1991) 1.92
Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med Care (1998) 1.88
Experience with reduced-size liver transplantation. Surg Gynecol Obstet (1990) 1.87
Use of Medicare hospital and physician data to assess breast cancer incidence. Med Care (1999) 1.85
Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am J Public Health (1994) 1.84
Preliminary taxonomic studies on the leprosy bacillus. Br J Exp Pathol (1975) 1.83
Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer (2000) 1.83
Perinatal factors and risk of breast cancer. Epidemiology (1996) 1.82
Cost of care for cancer in a health maintenance organization. Health Care Financ Rev (1997) 1.81
Outbreak of injection abscesses due to Mycobacterium abscessus. Arch Dermatol (1969) 1.80
Breast cancer risk and "delayed" primary Epstein-Barr virus infection. Cancer Epidemiol Biomarkers Prev (2001) 1.79
Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. Black/White Cancer Survival Study Group. J Natl Cancer Inst (1992) 1.77
BCG vaccination and cancer. Tubercle (1990) 1.76
An immunodiffusion analysis of strains of Mycobacterium ulcerans isolated in Australia, Malaya, Mexico, Uganda and Zaire. J Med Microbiol (1973) 1.76
Body size and breast cancer risk among women under age 45 years. Am J Epidemiol (1996) 1.75
Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology (1998) 1.73
Visualizing gene expression by whole-body fluorescence imaging. Proc Natl Acad Sci U S A (2000) 1.72
Expression of vascular endothelial growth factor receptors in human prostate cancer. Urology (1999) 1.71
Mycobacterium chelonei in abscesses after injection of diphtheria-pertussis-tetanus-polio vaccine. Am Rev Respir Dis (1973) 1.70
Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. Am J Hum Genet (1997) 1.68
Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer. J Urol (1996) 1.66
A co-operative numerical analysis of nonscoto- and nonphotochromogenic slowly growing mycobacteria. J Gen Microbiol (1974) 1.64